AVNT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Avient Corp (AVNT) does not present a strong buy opportunity for a beginner, long-term investor at this time. Despite some positive technical indicators, the company's recent financial performance is weak, hedge funds are selling, and there is no significant positive news or trading signals to suggest immediate upside potential. Holding off for now is the most prudent choice.
The technical indicators show mixed signals. The MACD is positive at 0.377, indicating bullish momentum, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI is neutral at 62.841, and the stock is trading near its resistance level (R1: 38.333). The stock's short-term trend suggests a 70% chance of a -1.73% decline in the next day and a -4.15% decline in the next week.
Some analysts have raised price targets recently, with Morgan Stanley increasing its target to $52 and Wells Fargo to $47, citing potential for positive earnings growth. The stock's moving averages are bullish, indicating some technical strength.
Hedge funds are selling heavily, with a 319.69% increase in selling activity last quarter. The company's Q4 2025 financials show a significant decline in net income (-65.01% YoY), EPS (-66.04% YoY), and gross margin (-13.15% YoY). Analysts have mixed opinions, with KeyBanc recently downgrading the stock to Sector Weight due to rising raw material costs. No recent news or significant events provide a clear positive catalyst.
In Q4 2025, revenue increased by 1.89% YoY to $760.6M, but net income dropped significantly by 65.01% YoY to $16.9M. EPS also declined sharply by 66.04% YoY to $0.18, and gross margin fell by 13.15% YoY to 30.19%. These results indicate weak profitability and margin compression.
Analysts have mixed ratings. KeyBanc downgraded the stock to Sector Weight, citing rising raw material costs. However, Morgan Stanley, Wells Fargo, and Baird raised price targets recently, reflecting cautious optimism for earnings growth in a challenging macro environment. The average price target is in the $45-$52 range, suggesting limited upside from the current price.
